Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
77.50
-1.70 (-2.15%)
Sep 4, 2026, 5:00 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
429382431372133172
Market Cap Growth
-16.12%-11.42%16.07%179.48%-22.49%-
Enterprise Value
368359394357130-
Last Close Price
77.5077.6087.6090.0038.8052.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.345.2211.1235.5125.8228.60
P/TBV Ratio
6.345.2211.1235.5125.8228.60

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.020.020.060.09
Net Debt / Equity Ratio
-0.90-0.93-0.85-0.87-0.74-0.92
Net Debt / EBITDA Ratio
3.684.702.320.670.451.37
Net Debt / FCF Ratio
2.924.891.840.600.471.37
Inventory Turnover
24.71-126.03---
Quick Ratio
22.4932.4918.665.231.943.41
Current Ratio
22.5632.5118.695.242.683.42
Return on Equity (ROE)
-33.35%-27.06%-59.03%-175.28%-160.02%-94.35%
Return on Assets (ROA)
-19.46%-16.23%-34.19%-85.92%-70.62%-42.35%
Return on Capital Employed (ROCE)
-25.30%-20.60%-37.70%-132.30%-165.70%-70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.98%-3.97%-3.37%-3.68%-6.71%-2.56%
FCF Yield
-4.83%-3.64%-4.13%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-8.77%-10.18%-15.76%-17.48%-5.54%-